Facial gestures, AI moves motorized wheelchair

Moving a motorized wheelchair typically involves a joystick or using a sensors. That may soon change after Hoobox Robotics, a Brazil-based technology company, teamed up with Intel to create software that uses AI to help the disabled drive motorized wheelchairs with facial expressions, according to a report by USA Today.

The Wheelie 7 kit learns a user’s smile and facial gestures, which are used to direct the wheelchair. With help from an app, the facial expressions are assigned to specific commands—such as stop, turn left or go backwards—for the wheelchair. Facial expressions that users can use to drive their wheelchair include: a kissing face, half smile, sticking out their tongue and raising or lowering their eyebrows, according to the report.

“Through a combination of facial recognition software, sensors, robotics and an Intel 3D RealSense Depth Camera that’s been mounted on the wheelchair, Wheelie captures a 3D map of the face uses AI algorithms to process the data in real time that directs the wheelchair,” the report said.

The Wheelie kit isn’t available to the public just yet. It’s currently a prototype being tested by about 60 people who have various disabilities, the report stated. However, the Hoobox company announced plans to “open up 100 additional spots on a waiting list” to try the kit. Those selected will get the kit for free in exchange for user feedback.

To read the full USA Today report, click the link below.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.